🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 12

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 12 of 20
B12Beth
Member
289
890
Oct 2024
Maryland
Jan 9, 2025 at 3:22 PM#56
jim_asheville said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Can confirm. Same sequence, different timescale. Posting only so the count is not one.

Last edited: Jan 9, 2025 at 6:22 PM
26 24GraceAZ_72, carl_compliance, DanielChem_CHI and 23 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Jan 17, 2025 at 9:59 PM#57
jim_asheville said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Coming at jim_asheville’s question from a different direction. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Ask again with the specifics and you will get a better answer than this one.

27 0ben_calgary, patPC_UT, Dr.DermMIA and 24 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jan 26, 2025 at 4:31 AM#58

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

28 1WendyG_ATL, SaraMom3, Dr.MetabolicMD and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nancy_portland
Member
345
1,567
Aug 2024
Portland, ME
Feb 3, 2025 at 10:59 AM#59

One thing that is still open after jim_asheville’s answer:

How would you tell the difference between that and the alternative explanation?

29 2Dr.PeteFamMed, claudia_zurich, nancy_portland and 26 others
Reply Quote Save Share Report
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Feb 11, 2025 at 5:22 PM#60

Found this through search years later and it is still the best discussion of the question, so adding one thing. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: Feb 11, 2025 at 10:22 PM
1 24Dr.LeslieOBGYN
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register